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Abstract 
Objectives: Adhesive capsulitis is a common cause of stiff shoulder and may result in pain and 
restriction of movement. The aim of this study was to investigate the role of hydrodilatation of the 
glenohumeral joint in the management of adhesive capsulitis. 
Methods: Patients referred from the shoulder clinic underwent hydrodilatation under ultrasound 
guidance. Of 209 referred for hydrodilatation, 163 underwent the procedure and attended follow-up 
physiotherapy. Outcome measures were available on 118 patients (58 men, 60 women). Mean age 
of the study group was 52.6 years.  
Results: There was a statistically significant improvement in both Oxford Shoulder Score (OSS) and 
Disability Arm Shoulder Hand Scores (Quick DASH) in the first four weeks after the procedure, which 
was maintained, but not improved to the end of the study period. Patients presenting with pain, 
those who had a history of steroid injections and older patients had worse functional scores at 
presentation. Diabetes (both Type I and II), previous physiotherapy, length of history and whether 
pain or stiffness or both were the predominant symptom did not have any statistical significance at 
presentation. These factors were not predictors of statistically significant improvement in functional 
scores.  
Conclusion: Hydrodilatation results in significant improvement of symptoms in patients with 
adhesive capsulitis. 
 
Article focus 
A combined service for managing the stiff shoulder using orthopaedics, physiotherapy and radiology 
was analysed using patient scoring systems. 
 
Key messages 
1. Hydrodilatation under ultrasound guidance is an effective treatment for the stiff shoulder. 
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Strengths and limitations 
1. Hydrodilatation is a minimally invasive procedure for the management of the non-
arthritic stiff shoulder. 
2. The procedure well tolerated. 
3. The multi-disciplinary team, (MDT),  of orthopaedic surgeons, physiotherapists and 
radiologists functioned well in our institution 
4. Loss to follow-up limited the size of our trial cohort. 
 
Introduction 
Stiff shoulder is a common presentation to the shoulder clinic; adhesive capsulitis, (commonly 
referred to as frozen shoulder), is the most common cause, affecting approximately 2-5%of the 
population1, 2. However later studies surmise that the real incidence of capsular contracture is about 
0.75% of the population as described by Bunker3. The condition is characterised by a thickening and 
contracture of the capsule akin to Dupuytren’s contracture of the hand3.  
Night pain with a reduced range of movement, particularly external rotation is one of the cardinal 
symptoms4. Frozen shoulder may be idiopathic or secondary to preceding trauma. Although older 
studies suggested a significant female preponderance5 more recent arthroscopic studies 
demonstrate a 1:1 male to female ratio and go on to suggest female preponderance if any is very 
small3. There is a strong association with diabetes mellitus6. The condition is usually self-limiting, 
typically lasting between 12-36 months7, with spontaneous resolution usually demonstrated, though 
some studies demonstrate up to 41% of patients had persisting symptoms associated with pain and 
functional loss8, 9.  
Three stages have been described in the past4 but it is accepted that the course of the disease can be 
variable3. Multiple treatment strategies have been suggested for the management of adhesive 
capsulitis, including manipulation under anaesthesia, surgical capsular release, physiotherapy 
regimens, intra-articular steroid injections , hydrodilatation of the gleno-humeral  joint (either using 
fluoroscopy10 or ultrasound11 guidance), or a combination of the above. Hydrodilation has been 
demonstrated to be more effective than physiotherapy12 and is also effective when compared with 
manipulation under anaesthesia13. Arthroscopic capsular release14 is an effective method of 
improving symptoms but is more invasive and expensive. Recent evidence suggests steroid injection 
into the rotator interval may be of benefit in this group of people15. Studies have suggested an 
improvement following hydrodilatation, usually with steroid in the injectate16-24.   
Hydrodilatation distends the gleno-humeral joint capsule with capsular rupture as the desired end-
point.  This study illustrates our strategy for managing stiff shoulder. 
 
Materials and methods 
Patient recruitment 
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Our stiff shoulder service is a multi-disciplinary team (MDT) approach between orthopaedics, 
physiotherapy and radiology.  Ethical approval was deemed unnecessary by our institutional review 
board. The aim of this study was to assess the efficacy of hydrodilatation of the gleno-humeral joint 
combined with intra-articular steroid injection and followed by a prescribed course of 
physiotherapy.   
An initial pilot study of twenty patients with primary stiff shoulder was performed.  Successful 
clinical outcomes were noted.  Our institution’s “New Procedures Committee” approved the 
technique for clinical use as part of a prospective clinical study. Appropriate consent procedures 
were established. 
209 patients with primary or secondary (but not post-operative), stiff shoulder were referred to the 
study from the shoulder clinics of the Newcastle upon Tyne teaching hospitals.  After the procedure, 
subjects were followed up in those clinics. Six patients who failed to improve with hydrodilatation 
were considered for other procedures where appropriate.    
Patients were recruited from 2011-14. Four patients with a proven full thickness rotator cuff tear 
were excluded as hydrodilatation is not effective in this group. 
 
Technique 
All procedures were carried out by one of two consultant musculoskeletal radiologists with the first 
author performing all the procedures in the initial pilot study. 
 Patients were requested to bring a family member/friend as an escort after the procedure and were 
also recommended not to drive post-procedure.  If any patient was on anticoagulant usual 
departmental policy for interventional procedures was followed.  
Radiographs of the shoulder were assessed to exclude osteoarthritis of the shoulder. History 
obtained included duration of symptoms, history of diabetes, previous steroid injections, 
physiotherapy, any co-existing medical condition was recorded, whether symptoms were worsening 
or plateaued prior to procedure and whether pain, stiffness or both were the predominant 
symptom.  
OSS (Oxford shoulder score) and Quick DASH (Disabilities of the arm, shoulder and hand) scores were 
also obtained immediately prior to the procedure. A diagnostic ultrasound of the shoulder was 
performed with a 9MHz curvilinear or 12.5MHz linear array ultrasound transducer (Phillips IU22 or 
Epiq 5) to confirm cuff integrity and exclude other cause of shoulder pain relating to the cuff, long 
head of biceps tendon, subacromial bursa or acromioclavicular joint. In the absence of contra-
indications the patient was consented including discussion of potential complications.   
The procedure was performed in the lateral position lying on the un-affected side. The probe was 
placed transversely across the posterior aspect of the glenohumeral joint  such that the glenoid 
labrum was in the middle of the screen. An appropriate site of puncture was marked. Using aseptic 
technique, 1% lidocaine was infiltrated into the skin and subcutaneous tissues. Under ultrasound 
guidance a 21G needle was placed into the glenohumeral joint via a postero-oblique approach. 
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Approximately 8-10ml Lignocaine 1% was then injected into the joint followed by a mixed injectate 
of 80mg triamcinolone, 15ml of 0.25% bupivacaine and 40-60mls of normal saline with phasic 
distension to the point of rupture.  If capsular rupture had not been achieved after instillation of 
60mls of normal saline the procedure was terminated.   
Five simple exercises aimed at increasing shoulder joint ranges of movement (flexion, abduction and 
rotations) were demonstrated to the patient, these were to be performed three times a day.  
Physiotherapy started the day after the procedure and continued as required and advised by the 
physiotherapist.  
Patients completed the Quick DASH and the OSS scores at four weeks, three, six and twelve months 
post-procedure.  
 
Figure 1. Ultrasound image on left showing needle tip position into the gleno-humeral joint with 
corresponding image on the right annotating various structures (humeral head outlined, glenoid 
outline in grey and posterior labrum in black).  
Results 
209 patients were referred for hydrodilatation during the study period. On presentation for the 
procedure 19 had improved and declined treatment, 11 patients did not attend the procedure; 
seven did not attend their initial physiotherapy appointment.  Nine procedures were abandoned for 
various reasons, (Table 1).  Six patients had subsequent procedures following failed hydrodilatation 
(Table 7).  
163 patients underwent hydrodilatation, with adequate post-procedure rehabilitation and data 
scores (at least 2 sets) available in 118. 
 Mean age was 52.6 years (range 28-73 years; Table- 2), 60 were female and 58 male and 26 suffered 
from diabetes mellitus.  
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Extremely tight capsule 1 
Breast carcinoma and radiotherapy 1 
Cuff tear 4 
Syncope prior to procedure 1 
Cerebral bleed prior to procedure 1 
Withdrawn consent 1 
Table 1: Indication for abandoning / not performing procedure. 
 
Age group in years Number of patients 
Less than 20 0 
21-30 2 
31-40 2 
41-50 31 
51-60 59 
61-70 21 
71-80 3 
Table 2: Age distribution of study group. 
Regression analysis of the pre-procedure OSS and Quick (QDASH) scores demonstrated that older 
patients, those who had undergone steroid injection/s and those who considered themselves to be 
in the worsening phase rather than in the plateau phase were functionally worse at the time of 
presentation.   No statistical difference in pre-procedure scores was noted between the diabetics 
and non-diabetics. Patients who had received prior physiotherapy did not have a statistically 
different score from those who had not; the duration of symptoms pre-procedure did not correlate 
with the scores at time of hydrodilatation. 
 Estimates std_errors t_stats p_values 
 OSS QDASH OSS QDASH 
OSS QDASH OSS QDASH 
Const 38.66 16.46 6.57 12.68 5.89 1.30 0.00 0.20 
Diabetes(y=1) 1.77 -1.48 2.38 4.59 0.74 -0.32 0.46 0.75 
Physio(y=1) -1.33 2.37 2.41 4.65 -0.55 0.51 0.58 0.61 
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Pain/stiffness/both(p=1) 0.42 -3.83 1.74 3.34 0.24 -1.15 0.81 0.25 
Plateau/worse(w=1) -5.74 13.50 2.30 4.43 -2.50 3.05 0.01 0.00 
Steroid>0 -4.41 9.26 2.16 4.17 -2.04 2.22 0.04 0.03 
Age(yrs) -0.22 0.50 0.11 0.22 -1.97 2.30 0.05 0.02 
Symptom duration(mth -0.02 0.05 0.07 0.13 -0.31 0.39 0.76 0.70 
ADj R2:    0.10 0.14       
 
Table 3: Regression analysis of pre-procedure scores. 
 
A significant improvement in functional scores was demonstrated at four weeks post- procedure, 
OSS score increasing by 14.99 (p=0.00) and the QDASH reducing by 26.82 (p=0.00).  
No statistical difference was observed in either score between four weeks and subsequent follow-
up, (Table 4).  
There has been a reduction in datasets available especially in the latter stages of patient follow-up 
with the largest set of scores (df) being available for the time period from procedure to 4 weeks i.e. 
79(OSS) and 80(QDASH) which reduced for the subsequent periods. 
 Mean t_stats df p_values 
 OSS QDASH OSS QDASH OSS QDASH OSS QDASH 
Between procedure and 4 weeks 14.99 -26.82 15.75 -15.20 79 80 0.00 0.00 
Between 4 weeks and 3 months 1.02 -3.34 1.36 -2.28 52 53 0.18 0.03 
Between 3 and 6 months -0.54 1.91 -0.56 0.95 34 34 0.58 0.35 
Between 6 months and 1 year 0.79 -4.97 0.44 -1.46 42 42 0.66 0.15 
 
Table 4: Demonstrates that the only significant consistent improvement occurs between the procedure 
and four weeks when using both OSS and QDASH scores. 
 
Regression analysis of the functional scores between the procedure and four weeks (table 5), 
demonstrated significant, (p=0.04), improvement in the QDASH scores of younger patients vs older 
patients, with a similar but not as significant (p=0.07) trend with the OSS scores. The other patient 
factors did not correlate with post-procedure scores.  
 Estimates std_errors t_stats p_values 
 OSS QDASH OSS QDASH OSS QDASH OSS QDASH 
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Const 4.31 0.10 7.44 13.90 0.58 0.01 0.56 0.99 
Diabetic -2.99 1.85 2.71 5.05 -1.10 0.37 0.27 0.72 
Prior physiotherapy -0.01 -1.73 2.74 5.11 0.00 -0.34 1.00 0.74 
Type of symptoms 
(pain/stiffness/both) 
0.19 3.73 2.02 3.73 0.10 1.00 0.92 0.32 
Stage of disease 
(plateau/worse) 
4.07 -7.82 2.65 4.95 1.53 -1.58 0.13 0.12 
Prior steroid injections -1.10 2.99 2.41 4.49 -0.46 0.67 0.65 0.51 
Age(years) 0.24 -0.51 0.13 0.24 1.87 -2.11 0.07 0.04 
Symptom duration (months) -0.11 -0.14 0.14 0.26 -0.76 -0.53 0.45 0.60 
ADJ R2:    0.01 0.01       
 
Table 5: analysis of patient factors - QDASH and OSS scores procedure to four weeks.. 
 
Discussion 
Stiff shoulder, with or without pain, is a common presenting symptom25. It represents a 
socioeconomic burden leading to significant work absence.26 
Incidence of stiff shoulder in General Practice is about 2.4 per 1000 head of population per year27.   
Referral to secondary care varies but UK data suggest only 22% patients were referred during the 
three years from initial presentation28.  
Many strategies have been described to reduce the level of pain or the duration of symptoms. We 
feel management of these patients within the current NHS primary care and secondary / tertiary 
musculo-skeletal services is often fragmented.  We believe that composite MDT approach improves 
and hastens the treatment of the condition.  
Gleno-humeral osteoarthritis can mimic frozen shoulder.  All stiff shoulders should therefore be x-
rayed. 
Referral from primary care to specialist clinics is often delayed, (table 6). 
Duration of symptoms to hydrodilatation Number of patients 
0-6months 18 
7-12 months 63 
13-24 months 28 
>24 months 9 
Table 6 Referral delays for hydrodilatation. 
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Regression analysis of scores at presentation suggest patients in the worsening stage were on 
average 13.5 points worse off on Quick DASH and 5.74 points worse off on OSS compared to the 
plateau stage. Patients who had at least one prior steroid injection had Quick DASH scores and OSS 
scores which were worse off by 9.26 and 4.41 points respectively. The scores also reveal that for 
every additional year age the Quick DASH and OSS scores were worse by a factor of 0.5 and 0.22 
respectively. 
Our experience suggests that ultrasound guidance is superior to fluoroscopy as it allows 
confirmation of cuff integrity, (allowing sufficient pressure for capsular rupture if achievable), and to 
exclude alternate local pathologies.  
Our results demonstrate a statistically significant improvement in shoulder function and symptoms 
within four weeks of the procedure. This improvement was maintained to the end of the study 
period. 
Given the initial results we observed on the patients with primary stiff shoulders, we subsequently 
performed the procedure in the later part of the study on some patients with secondary stiff 
shoulders. However we do not have adequate data and consider this aspect to be part of a future 
study. 
The authors believe that it is vitally important to start exercising on the day of hydrodilatation and 
have a physiotherapy appointment the day after. However we will be assessing the role of 
physiotherapy in a future study. 
Age does not appear to be a significant predictor of response to hydrodilatation. Results 
demonstrated (Table 5) that although there was some statistical significance on QDASH scores (p= 
0.04), but this was not mirrored in the OSS scores (p= 0.07). However, there might be an underlying 
trend here. 
There is a higher incidence of adhesive capsulitis in the diabetic population6, our study had 22% 
patients who were diabetics. There was no difference in outcome between the diabetics to the non-
diabetics in our study group - this concurs with a previous study by Clement et al29.  
There was also no statistical significance to the functional outcome in hydrodilatation patients who 
had previous physiotherapy, whether they recorded pain or stiffness or both as the predominant 
symptom and whether patients felt they were in the plateau or worsening stage.  
Six patients required surgery post hydrodilatation. These patients are regarded as ‘failure of the 
procedure’. Three patients underwent an arthroscopic capsular release, two had manipulation under 
anaesthetic and one went on to have cervical spinal surgery. No common factors were 
demonstrated in this small sub-group of patients. All three participating surgeons saw a large 
reduction in the number of ‘stiff shoulder ‘procedures performed during the study period. 
Arthroscopic capsular release 2 
Manipulation under anesthesia 2 
Subacromial decompression and capsular release 1 
Cervical decompression for disc prolapse 1 
Table 7: Post hydrodilatation surgery 
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The procedure was well tolerated by all patients. Our patient group experienced few adverse events 
/ complications of the procedure. One patient developed transient suprascapular nerve palsy 
because of leakage of anaesthetic into the supraglenoid notch region. Patients often feel some 
discomfort and sometimes feel dizzy in the first few minutes of / after the procedure. We advised 
our patients to be accompanied for the procedure and not to drive for the rest of the day.  
Table 8 demonstrates the reduction in surgical procedures (manipulation under anaesthesia or 
arthroscopic capsular release) for stiff shoulder in the four years after the start of the study period. 
This represents a 78.5% reduction in surgical treatment.  
The procedure takes an hour to perform in our ultrasound department, with the patient free to 
leave once the procedure is completed.  This compares favourably to surgical procedures. 
Before  After  
2007 14 2011 3 
2008 18 2012 2 
2009 10 2013 3 
2010 14 2014 4 
Total 56 Total 12 
Table 8: Surgical rates pre / post study. Our current management follows the algorithm below: 
 
 
 
                                         
                                    
 
 
 
 
 
 
Figure 2: Flow pattern for management of frozen shoulder 
A review in 2012 concluded there was limited clinical evidence on the effectiveness of treatments 
for primary frozen shoulder and that the studies which have been published in this area have all 
suffered from small participant numbers30. This study demonstrates with statistical significance, the 
Shoulder clinic: managed by 
specialist physiotherapists and 
upper limb surgeons 
Community GP Other Depts. e.g. 
Rheumatology 
Physiotherapy 
Confirmed stiff shoulder. Other 
causes excluded. 
Refer to radiology for 
hydrodilatation 
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effectiveness of hydrodilatation in a large cohort. At our institution, the estimated cost of a surgical 
release is £1015 whilst for hydrodilatation is £282 as per currently priced coding guidelines, which 
represents a saving to the trust of £733 per case.  
 
Conclusion 
 We have demonstrated that hydrodilatation under ultrasound guidance followed by physiotherapy 
is an effective management option for the stiff shoulder. 
We have found that the MDT approach to the stiff shoulder has improved our management of this 
group of patients and markedly reduced our requirement for surgical procedures.  
We propose that the establishment of a ‘stiff shoulder clinic’ run by specialist physiotherapists 
within the consultant led shoulder clinic with rapid access to hydrodilatation could hasten the 
resolution of patient’s symptoms, facilitate an early return to work and sport.  The reduction in 
surgical procedure will lead to considerable financial savings for the NHS and at the same time 
create a non-operative pathway for the management of this condition. 
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